Global Dermal grafts market Projected to generate significant sales for the market players over the forecast period

15/mag/2018 06:54:45 sravan Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Dermal grafts market  Projected to generate significant sales for the market players over the forecast period

 

How dermal graft has become a life savior?

Global Dermal grafts market: Dermal grafting is the procedure in which the part of the skin is replaced with the skin from other parts of the body. A dermal graft is used to replace damaged or missing skin or to provide a temporary wound covering. Dermal grafting is performed or recommended for skin infections, injury, deep burns, skin cancer, pressure ulcers and reconstructive surgeries. There are two types of skin grafts Viz. the split-level thickness and full thickness. Split-level thickness includes removal of dermal and epidermal layers of the skin and full-thickness grafts involve removal of muscles and blood vessels.  Patients with deeper tissue loss need a full-thickness skin graft to cover the wound. This requires an entire thickness of skin from the donor site, not just the top two layers.

 

Dermal grafts market is driven by rise in the incidence of burns, accidents and surgeries requiring removal of skin. In addition factors such as skin loss due to cancer and infection are boosting the demand for dermal grafts. According to Skin Cancer Foundation, each year over 5.4 Mn cases of non-melanoma skin cancer are reported and over 3.3 Mn people are treated for the same in the U.S. Furthermore, technological advances in dermatomes such as electric and air dermatomes, increased accuracy and control by using exchangeable blades are the factors expected to bolster skin grafts market over the forecast period. However, complications of dermal grafts such as infection, pain, high cost of the procedure, and tissue rejection are some of the factors hindering the growth of the global dermal grafts market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-grafts-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Dermal grafts market is divided into following categories- 

1.      Equipment

·         Knives Dermatomes

·         Electric Dermatomes

·         General Surgical Instruments

·         Consumables

·         Air Dermatomes

 

2.     Graft type

·         Autologous

·         Isogenic

·         Allogeneic

·         Xenogeneic

·         Prosthetic

 

3.     Thickness

·         Split Thickness

·         Full Thickness

·         Composite Graft

 

4.     Applications

·         Burns

·         Extensive Wound

·         Skin Cancer

·         Infection

·         Others

 

5.     End-users

Hospitals, dermatology clinics and ambulatory surgical centers.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-grafts-market/#ulp-c654SbFYO64MsOhu

 

And lastly on the basis of geographical regions, dermal grafts market has been segmented into following regions- North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the significant market share owing to favorable reimbursement policies and higher healthcare expenditure. Adaptation of new technologies and increased skin related diseases are boosting the North America dermal grafts market. Europe dermal grafts market driven by large disposable income and rising awareness of newer technologies in dermal grafting among key stakeholders. Asia Pacific dermal grafts market region is projected to have the fastest growth and is expected to lead by growing economies such as India and China. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to show minimal growth rate due to poor healthcare infrastructure and market penetration.

 

Some of the key players in skin grafts market include Organogenesis, Inc. (U.S.), Stratatech Corp. (U.S), Avita Medical (U.K.), ConvaTec Group plc. (U.K.), Coloplast (Denmark), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany), Medtronic (Stratatech Corporation) (U.S.), Zimmer Biomet. (U.S.), Nouvag AG (Switzerland), Tissue Regenix Group PLC (U.K), and Allergan Plc (Ireland). In 2017, Allergan plc, acquired LifeCell Corporation, a leading regenerative medicine company. LifeCell Corporation portfolio include, Alloderm, a human allograft tissue matrix used in breast reconstruction post-mastectomy, and revolve, a single use high-volume fat grafting device used in plastic and reconstructive procedures. Additionally, LifeCell markets strattice, porcine based tissue matrix used in complex abdominal wall repair and for the surgical repair of damaged or ruptured soft tissue. And in 2016, Integra LifeSciences Corporation’s omnigraft dermal regeneration matrix received new indication from the USFDA to treat certain diabetic foot ulcers.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-grafts-market/#ulp-14mlyhjMGhVjZqa3

 

Global issues such as fire accidents and burns have a major impact on growth of dermal grafts market. Market is mainly driven by increasing adoption of the dermal grafts globally due to increasing socioeconomic status. Development of health care accessibility and infrastructure expected to fuel the hospital end user segment in the global skin grafts market. Market players globally adopting innovation in grafting technologies to increase their market share. In addition, acquisitions, mergers are key strategies adopted by market players. For example, in 2016, Mallinckrodt Plc., a leading specialty pharmaceutical company, acquired Stratatech Corporation, a privately held regenerative medicine company focused on the development of unique, proprietary skin substitute products, such as stratagrafts regenerative skin tissue and a technology platform for genetically enhanced skin tissues. Similarly, in 2014, Organogenesis Inc., a commercial leader in the field of regenerative medicine has acquired the Dermagraft assets (human fibroblast-derived dermal substitute) from Shire Plc.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-grafts-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl